Vita Therapeutics is a cell engineering company that develops life-transformative treatments.
Vita Therapeutics has raised $31.0M in total funding. The most recent round was Series B. The last funding was announced in October 2022.
Vita Therapeutics's investors include TEDCO, Cambrian Biopharma, Cedars Sinai, Early Light Ventures, Solve FSHD.
Vita Therapeutics is headquartered in Baltimore, United States.
Vita Therapeutics is a cell engineering company that develops life-transformative treatments.
Vita Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vita Therapeutics — Funding & Investors." VCBacked, October 12, 2022, https://www.vcbacked.co/company/vita-therapeutics. Accessed August 10, 2026.
VCBacked. (2022). Vita Therapeutics — Funding & Investors. Retrieved August 10, 2026, from https://www.vcbacked.co/company/vita-therapeutics
{{cite web |title=Vita Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/vita-therapeutics |website=VCBacked |access-date=August 10, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated